Search

Padmashri Ponnaluri

Examiner (ID: 16123, Phone: (571)272-0809 , Office: P/3991 )

Most Active Art Unit
3991
Art Unit(s)
3991, 1627, 1639, 1648, 1618, 1818
Total Applications
819
Issued Applications
522
Pending Applications
126
Abandoned Applications
175
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
16/822809 ANNEXIN 1 ANTIBODY Mar 17, 2020 Abandoned
90/014449 METHOD OF MANUFACTURING VEGF ANTAGONIST FUSION PROTEINS Feb 10, 2020 Issued
16/784053 Multivalent Breast Cancer Vaccine Feb 5, 2020 Abandoned
96/000310 COMBINATION THERAPY Jan 20, 2020 Pending
90/014423 DNA SEQUENCES, RECOMBINANT DNA MOLECULES AND PROCESSES FOR PRODUCING HUMAN FIBROBLAST INTERFERON-LIKE POLYPEPTIDES Dec 19, 2019 Issued
Array ( [id] => 17451209 [patent_doc_number] => RE048960 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-03-08 [patent_title] => Antisense oligonucleotides for inducing exon skipping and methods of use thereof [patent_app_type] => reissue [patent_app_number] => 16/721681 [patent_app_country] => US [patent_app_date] => 2019-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 15761 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => -59 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721681 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/721681 		Antisense oligonucleotides for inducing exon skipping and methods of use thereof Dec 18, 2019 Issued
90/014395 Nucleic Acid Vaccines Oct 23, 2019 Issued
90/014318 ENHANCED NUCLEIC ACID CONSTRUCTS FOR EUKARYOTIC GENE EXPRESSION Jun 18, 2019 Issued
90/014320 ENHANCED NUCLEIC ACID CONSTRUCTS FOR EUKARYOTIC GENE EXPRESSION Jun 18, 2019 Issued
90/014299 BISPECIFIC SCFV IMMUNOFUSION (BIF) May 2, 2019 Issued
Array ( [id] => 18070016 [patent_doc_number] => RE049340 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-12-20 [patent_title] => Use of known compounds as D-amino acid oxidase inhibitors [patent_app_type] => reissue [patent_app_number] => 16/401892 [patent_app_country] => US [patent_app_date] => 2019-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7288 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16401892 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/401892 		Use of known compounds as D-amino acid oxidase inhibitors May 1, 2019 Issued
Array ( [id] => 18070015 [patent_doc_number] => RE049339 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-12-20 [patent_title] => Antibodies to the C3D fragment of complement component 3 [patent_app_type] => reissue [patent_app_number] => 16/380941 [patent_app_country] => US [patent_app_date] => 2019-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 47812 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16380941 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/380941 		Antibodies to the C3D fragment of complement component 3 Apr 9, 2019 Issued
16/373459 MEANS AND METHODS FOR COUNTERACTING MUSCLE DISORDERS Apr 1, 2019 Abandoned
16/373429 MEANS AND METHODS FOR COUNTERACTING MUSCLE DISORDERS Apr 1, 2019 Abandoned
16/353978 MEANS AND METHODS FOR COUNTERACTING MUSCLE DISORDERS Mar 13, 2019 Abandoned
Array ( [id] => 17191471 [patent_doc_number] => RE048805 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2021-11-02 [patent_title] => Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein [patent_app_type] => reissue [patent_app_number] => 16/244228 [patent_app_country] => US [patent_app_date] => 2019-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 14 [patent_no_of_words] => 9341 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16244228 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/244228 		Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein Feb 11, 2019 Issued
16/249759 MEANS AND METHODS FOR COUNTERACTING MUSCLE DISORDERS Jan 15, 2019 Abandoned
16/249777 MEANS AND METHODS FOR COUNTERACTING MUSCLE DISORDERS Jan 15, 2019 Abandoned
16/228404 PRO-ANGIOGENIC PEPTIDES AND USES THEREOF Dec 19, 2018 Abandoned
16/223294 TUMOR-SPECIFIC MINICIRCLES FOR CANCER SCREENING Dec 17, 2018 Abandoned
Menu